Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus

Molecular Psychiatry

Volumn 7, Issue 6, 2002, Pages 579-593

  Sklar, P ^a,b,c   Gabriel, S B ^c   McInnis, M G ^d   Bennett, P ^e   Lim, Y M ^c   Tsan, G ^c   Schaffner, S ^c   Kirov, G ^f   Jones, I ^e   Owen, M ^f   Craddock, N ^e   DePaulo, J R ^d   Lander, E S ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Genomic; Linkage; Single nucleotide polymorphism; SNP; Susceptibility loci; Transmission disequilibrium test

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CHANNEL; PROTEIN SUBUNIT;

ALLELE; ARTICLE; CHANNEL GATING; DISEASE TRANSMISSION; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MARKER; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MOLECULAR GENETICS; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLING; SINGLE NUCLEOTIDE POLYMORPHISM; VOLTAGE CLAMP; BIPOLAR DISORDER; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; FAMILY; GENETICS; MULTICENTER STUDY; RISK FACTOR; UNITED STATES;

BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHI-SQUARE DISTRIBUTION; FAMILY; HAPLOTYPES; HUMAN; IOWA; MARYLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036347948     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001058     Document Type: Article

References (76)

1. A generalization of the transmission/disequilibrium test for uncertain- haplotype transmission
2. Genetics of manic depressive illness
3. Relationship between schizoaffective illness and affective disorders or schizophrenia. Morbidity risk and genetic transmission
4. Genetic linkage between X-chromosome markers and bipolar affective illness
5. Bipolar affective disorders linked to DNA markers on chromosome 11
6. A locus for bipolar affective disorder on chromosome 4p
7. A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder
8. Familial cosegregation of major affective disorder and Darier's disease (keratosis follicularis)
9. Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1
10. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in Quebec points to a locus of major effect on chromosome 12q23-q24
11. Significant linkage between bipolar affective disorder and chromosome 12q24
12. A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3
13. Affected-sib-pair analyses reveal support of prior evidence for a susceptibility locus for bipolar disorder, on 21q
14. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 4, 7, 9, 18, 19, 20, and 21q
15. Two-locus admixture linkage analysis of bipolar and unipolar affective disorder supports the presence of susceptibility loci on chromosomes 11p15 and 21q22
16. Evidence for linkage of bipolar disorder to chromosome 18 with a parent- of-origin effect
17. Linkage of bipolar affective disorder to chromosome 18 markers in a new pedigree series
18. An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees
19. Use of linkage disequilibrium approaches to map genes for bipolar disorder in the Costa Rican population
20. Chromosome 18 DNA markers and manic-depressive illness: Evidence for a susceptibility gene
21. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
22. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
23. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
24. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
25. Mutation in blood coagulation factor V associated with resistance to activated protein C
26. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
27. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
28. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
29. Assessment of lineality in bipolar I linkage studies
30. Full-genome scan for linkage in 50 families segregating the bipolar affective disease phenotype
31. Clinical criteria for psychiatric diagnosis and DSM-III
32. Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees
33. Bipolar disorder and the serotonin transporter gene: A family-based association study
34. Characterization of single-nucleotide polymorphisms in coding regions of human genes
35. Solid-phase reversible immobilization for the isolation of PCR products
36. Fluorescence energy transfer detection as a homogeneous DNA diagnostic method
37. Template-directed dye-terminator incorporation (TDI) assay: A homogeneous DNA diagnostic method based on fluorescence resonance energy transfer
38. Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse
39. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip- based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
40. A comparison of linkage disequilibrium measures for fine-scale mapping
41. A high-density genome scan detects evidence for a bipolar-disarder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2
42. Lack of association between bipolar affective disorder and tyrosine hydroxylase DNA marker
43. Analysis of the tyrosine hydroxylase and dopamine D4 receptor genes in a Croatian sample of bipolar I and unipolar patients
44. Lack of association between bipolar disorder and tyrosine hydroxylase: A metaanalysis
45. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder
46. Association between the tryptophan hydroxylase gene and manic- depressive illness
47. Tryptophan hydroxylase gene and manic-depressive illness
48. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients
49. Genetic association analysis of serotonin system genes in bipolar affective disorder
50. Lack of association between tryptophan hydroxylase gene and psychotic symptomatology in schizophrenia
51. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors
52. Initial genome screen for bipolar disorder in the NIMH genetics initiative pedigrees: Chromosomes 2, 11, 13, 14, and X
53. Trkb encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor
54. Human and rat brain-derived neurotrophic factor and neurotrophin-3: Gene structures, distributions, and chromosomal localizations
55. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor
56. Sensory but not motor neuron deficits in mice lacking NT4 and BDNF
57. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex
58. Neurotrophins and depression
59. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)
60. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities
61. Genetic covariation between neuroticism and the symptoms of anxiety and depression
62. Bipolar disorder, unipolar depression and the Five-Factor Model of personality
63. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families
64. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia
65. Heritability of BDNF alleles and their effect on brain morphology in schizophrenia
66. Neuroimaging in bipolar disorder
67. Neuroanatomical studies on bipolar disorder
68. Neuroanatomical studies on bipolar disorder
69. Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia
70. The anatomy of mood disorders - Review of structural neuroimaging studies
71. Subgenual prefrontal cortex abnormalities in mood disorders
72. Hippocampal atrophy in recurrent major depression
73. Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions
74. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS
75. Neuronal cell death
76. Characterization of MALS/Velis-1, -2, and -3: A family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex